| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eef0ce98d7fd2740f70edbfa022071de |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
1976-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1977-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e9794d4bff1c777679449f2c2e41dc |
| publicationDate |
1977-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4049791-A |
| titleOfInvention |
Prolonged acting appetite suppressant and anti-obesity compositions containing amphetamine adipate, dextroamphetamine adipate, amphetamine sulfate and dextroamphetamine sulfate as the active agents |
| abstract |
A prolonged acting appetite suppressant and anti-obesity composition in oral administration form which comprises an effective amount of a synergistic combination of amphetamine adipate, dextroamphetamine adipate, amphetamine sulfate and dextroamphetamine sulfate in equal or substantially equal amounts as the active agents in combination with a pharmaceutically acceptable carrier and is useful in suppressing one's appetite and in treating obesity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005158384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004059002-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6913768-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE41148-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42096-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4443428-A |
| priorityDate |
1974-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |